Is pCR a Reliable Survival Surrogate in Breast Cancer Trials? Is pCR a Reliable Survival Surrogate in Breast Cancer Trials?

Pathologic complete response (pCR) is not a reliable surrogate endpoint in neoadjuvant therapy trials for early breast cancer; alternatives are needed, researchers said.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news